Advisor Group Holdings, Inc. Ionis Pharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

$42.1 Billion
Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,373 shares of IONS stock, worth $87,231. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,373

Previous 15,964 85.14%

Holding current value

$87,231

Previous $558,000 87.28%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$30.17 - $34.97 $410,040 - $475,277	-13,591 Reduced 85.14%	2,373 $71,000
Q4 2024 Jun 06, 2025	BUY	$33.73 - $40.36 $54,406 - $65,100	1,613 Added 67.97%	3,986 $139,000
Q4 2024 Feb 07, 2025	SELL	$33.73 - $40.36 $13,761 - $16,466	-408 Reduced 2.49%	15,964 $558,000
Q3 2024 Nov 13, 2024	BUY	$40.06 - $51.86 $67,300 - $87,124	1,680 Added 11.43%	16,372 $655,000
Q2 2024 Aug 13, 2024	BUY	$36.45 - $47.7 $2,405 - $3,148	66 Added 0.45%	14,692 $700,000
Q1 2024 May 10, 2024	SELL	$42.03 - $53.55 $180,056 - $229,408	-4,284 Reduced 22.65%	14,626 $634,000
Q4 2023 Feb 12, 2024	BUY	$43.39 - $51.63 $323,776 - $385,263	7,462 Added 65.18%	18,910 $956,000
Q3 2023 Nov 13, 2023	BUY	$38.5 - $47.13 $103,449 - $126,638	2,687 Added 30.67%	11,448 $519,000
Q2 2023 Aug 10, 2023	SELL	$34.73 - $43.33 $26,881 - $33,537	-774 Reduced 8.12%	8,761 $359,000
Q1 2023 May 12, 2023	SELL	$33.58 - $41.2 $43,452 - $53,312	-1,294 Reduced 11.95%	9,535 $340,000
Q4 2022 Feb 10, 2023	SELL	$37.12 - $46.52 $26,206 - $32,843	-706 Reduced 6.12%	10,829 $409,000
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $215,184 - $286,558	-5,889 Reduced 33.8%	11,535 $510,000
Q2 2022 Aug 10, 2022	SELL	$31.71 - $43.0 $67,922 - $92,106	-2,142 Reduced 10.95%	17,424 $646,000
Q1 2022 May 04, 2022	BUY	$29.88 - $37.04 $33,615 - $41,670	1,125 Added 6.1%	19,566 $728,000
Q3 2021 Nov 05, 2021	SELL	$33.54 - $40.55 $82,575 - $99,834	-2,462 Reduced 11.78%	18,441 $619,000
Q2 2021 Aug 02, 2021	BUY	$34.54 - $47.25 $170,523 - $233,273	4,937 Added 30.92%	20,903 $833,000
Q1 2021 May 13, 2021	BUY	$42.51 - $63.78 $110,015 - $165,062	2,588 Added 19.35%	15,966 $720,000
Q4 2020 Feb 10, 2021	BUY	$45.3 - $60.27 $35,968 - $47,854	794 Added 6.31%	13,378 $757,000
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $99,502 - $132,006	-2,097 Reduced 14.28%	12,584 $595,000
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $51,722 - $67,399	1,104 Added 8.13%	14,681 $867,000
Q1 2020 May 18, 2020	BUY	$41.6 - $63.4 $564,803 - $860,781	13,577 New	13,577 $643,000

Others Institutions Holding IONS

# of Institutions

401

Shares Held

146M

Call Options Held

916K

Put Options Held

552K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.22B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Ionis Pharmaceuticals Inc Transaction History